Producer prices rose less than forecast for October but 6.5% from a year earlier. Cerebras closed up 11% after raising its forecast. Washington sued a state on Thursday to protect prediction markets.

THE NUMBER

24%.

That is how fast Cisco (CSCO) grew sales last quarter, to $18.5 billion. It beat forecasts, raised its outlook for the year and still gave back its after-hours gain. The weak spot was margin. Product gross margin fell 3.5 points, which the company tied to more hardware and costly memory. Its per-share profit guide for next quarter is below what it just earned. The shares closed down 6.2% Friday.

A beat and a raise were not enough to hold the price.

PREMIER FEATURE

Lately Every Top Stock List Has Started Looking the Same.

Nothing wrong with Nvidia, Tesla, or SpaceX, but we believe there are plenty of other top-quality opportunities for investors willing to dig into the details.

That's why our MarketBeat analysts built an all-new list of the 5 Best Stocks to Buy Now.

Every company on the list:

  • Worth at least $5 billion
  • Strong fundamentals
  • Strong growth prospects ahead

You'll get the full bull case, and the full bear case, for each stock. Every opportunity, every risk, every factor we considered. So you can invest with confidence.

The report is called 5 Stocks to Buy Now, and it's yours free today.

Send My Free Report

THE SETUP
  • October producer prices rose 0.3%, less than the 0.4% forecast. From a year earlier they rose 6.5%, the most since November 2022. A core gauge that leaves out food, energy and trade rose 0.5% for a second month.
  • The 10-year Treasury yield touched about 5.17% and closed near 5.16%. Boston Fed President Susan Collins said more tightening would soon be right. A December hike is still priced in.
  • The S&P 500 fell 0.4% and the Nasdaq-100 fell 1.2%. The Dow edged up 0.1%, and Brent crude ended near $96, little changed.
  • AMD (AMD) closed down 8.8%, giving back Thursday's gain and more. Chip stocks fell across the board, and Nvidia (NVDA) closed down 2%. Nvidia reports Tuesday.
FROM OUR PARTNERS

Jim Rickards Predicts: Trump's Next Big Buy

This tiny $2 stock holds the exclusive rights to the largest gold reserve in the country.

And it has the potential to be the biggest fortune maker in Trump’s second term.

According to Jim Rickards...

Trump is about to take a direct stake in this $2 stock.

And if you’d like to learn how to stake your claim in this asset before President Trump and his administration make a move…

You need to act before November 3rd.

Click here to see Jim’s big prediction: “Trump’s Next Big Buy.”

IN FOCUS

A Buyout Firm Co-Led a $1 Billion Series A. No Price Was Disclosed.

Mirendil, an AI start-up, said Thursday it raised $1 billion in a Series A round. Kleiner Perkins and Clearlake Capital co-led it. Google (GOOGL), Battery Ventures and other investors also took part. The company did not disclose a valuation. It raised a $200 million seed round in June.

Clearlake is the odd name here. Buyout firms usually buy steady cash flow, borrow against it and sell later. A Series A has no cash flow to borrow against. Yet a firm built on debt and control helped lead this round, about five months after the seed.

Mirendil gave no reason for the pairing. One reading fits the wider market. Exits have slowed, and sponsors are holding companies longer. Their committed money also comes with a deadline. Big AI rounds are one of the few places to put a billion dollars to work fast.

Where buyers set a price in public, the test was harder. vVARDIS (VVVV) priced its IPO at $18 on Thursday and opened at $14 on Friday. It closed at $16.50, still 8% below its offering price. Mirendil's backers put in $1 billion and did not say what they paid.

A Billion Dollars, No Price Tag.

For buyout fund investors, this can mean start-up risk inside a fund sold on control and cash flow. Money is at stake because start-up bets rarely come with loan terms or control. It is also carried at a private mark that no sale has tested. The fund behind the check, and whether other buyout firms follow, would show if this is a shift.

SIGNALS IN MOTION

SIGNAL 1: Cerebras Raised Its Forecast and Named Microsoft. The Shares Jumped.

Cerebras (CBRS) raised its fourth-quarter sales forecast well above what analysts expected. The midpoint of the new range tops estimates by 16% to 18%. Its chief executive named Microsoft (MSFT) as a new customer. Revenue from that deal is due to start next year. The shares closed up 11.2% Friday.

The company still lost money on a reported basis. OpenAI made up 32% of its sales in the June quarter. Cisco and Cerebras both beat and raised, and only Cerebras rose. Cisco's raise came with thinner margins and a next-quarter profit guide below this quarter's. Cerebras added customers.

WHAT RESOLVES THIS

For holders, the raise came with a few very large customers attached. Money is at stake because big buyers can switch suppliers, and that limits pricing. A second large customer spreads the risk but does not remove it. A full customer breakdown, and whether the shares hold the jump, would show if the move lasts.

SIGNAL 2: Washington Sued a State to Defend Prediction Markets. Another State Won an Order Against Them.

The Justice Department and the futures regulator sued Arkansas's attorney general on Thursday. They argue that federal law on futures overrides state gambling law. They want to stop state action against Kalshi and similar venues. Polymarket's U.S. arm had sued the same official on Nov. 9.

The same day, Louisiana's attorney general said she won a temporary restraining order. It requires the platforms to block users in the state. The order's text has not been published. Kalshi has asked a federal court for its own injunction.

WHAT RESOLVES THIS

For investors in these venues' private rounds, value rests on the size of the market. A product sold in every state is worth far more than one that must be blocked state by state. A restraining order is not a ruling, and a lawsuit is not a judgment. A Louisiana hearing is reported for Nov. 30, and the Supreme Court case has a Dec. 7 date. Those will show which way this leans.

PARTNER SPOTLIGHT

Why Did Trump Just Ban America's Most Powerful AI?

It's not Nvidia. It's not OpenAI. It's not Google.

It's a San Francisco AI lab whose technology is used by eight of the ten largest companies in America — and which Bloomberg calls the highest-revenue AI company on earth.

Trump banned it from every federal agency and the Pentagon blacklisted it. The reason isn't what you think. Full details here.

WHAT MOST WILL MISS
  • Twenty One Capital (XXI) reported third-quarter profit of $1.09 billion. Almost all of it came from marking its bitcoin at about $83,700. Bitcoin traded near $68,400 late Friday, about 18% below that mark.
  • Nakamoto (NAKA) fell 13.6% after it posted negative operating revenue. A $5.8 million options loss outweighed its business sales. Its 165 million tether loan from Kraken already exceeded its stock market value. That value is now about $87 million.
  • Bitcoin briefly climbed back above $70,000 after the price data, then slipped below $69,000. A softer monthly reading did not hold it up.
THE CROSSOVER

Private Market Trends Driving Public Market Moves

Public Buyers Charged for Beats. Private Money Paid Without a Price.

On Thursday, Mirendil raised $1 billion with a buyout firm as co-lead and gave no valuation. On Friday, the 10-year touched 5.17%, and public buyers sold Cisco after a beat and a raise. Cerebras, which added customers along with its higher forecast, was the one that got paid. vVARDIS ended its first day 8% below its IPO price. Twenty One's profit rests on a bitcoin price about 18% above Friday's. Our read is that a higher cost of money raises the bar wherever a price is set every day. Where no price is shown, that bar is harder to see. Anthropic is expected to price its IPO next week, per reports. That will put a public price on a large private AI company.

On the calendar...

When

Event

Mon., Nov. 16

vVARDIS offering expected to close

Tue., Nov. 17

Nvidia reports; retail sales

Wed., Nov. 18

Fed minutes; Anthropic pricing expected, per reports

Tue.-Wed., Dec. 8-9

Fed meeting

The Next AI Race Isn't About the Best Model.

Models improve. Computing gets cheaper. An algorithm can be matched.
What's hard to copy is a company's own lab data: experiments run at industrial scale, with every result fed back to make the AI smarter.
In drug development, that loop may become the edge that matters most. Not who has the best model. Who can learn biology fastest.
We profiled 5 companies building that loop in a new FREE Special Report: AI Moves Into the Biotech Lab.
We'll text it straight to your phone.

Get the Free Report by Text →